WALPAR NUTRITIONS Stock Price Today (NSE: WALPAR)
Fundamental Score
WALPAR NUTRITIONS Share Price — Live NSE/BSE Price, Fundamentals & Analysis
WALPAR NUTRITIONS share price today is ₹34.85, up +0.00% on NSE/BSE as of 3 August 2026. WALPAR NUTRITIONS (WALPAR) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹32.40 (Cr). The 52-week high for WALPAR share price is ₹50.60 and the 52-week low is ₹21.25. At a P/E ratio of 13.12x, WALPAR is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 13.93% and a debt-to-equity ratio of 0.89.
WALPAR NUTRITIONS Share Price Chart — NSE/BSE Historical Performance
WALPAR NUTRITIONS share price chart: 25.36% return over the past month. 52-week high ₹50.60, 52-week low ₹21.25.
WALPAR NUTRITIONS — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹34.85 | ₹34.85 | ₹34.85 | ₹34.85 | 0.00 (Cr) | |
| ₹34.85 | ₹34.85 | ₹34.85 | ₹34.85 | 0.00 (Cr) | |
| ₹34.85 | ₹34.85 | ₹34.85 | ₹34.85 | 0.00 (Cr) | |
| ₹34.85 | ₹34.85 | ₹34.85 | ₹34.85 | 0.00 (Cr) | |
| ₹34.85 | ₹34.85 | ₹34.85 | ₹34.85 | 0.00 (Cr) | |
| ₹34.85 | ₹34.85 | ₹34.85 | ₹34.85 | 0.00 (Cr) | |
| ₹34.85 | ₹34.85 | ₹34.85 | ₹34.85 | 0.00 (Cr) | |
| ₹34.85 | ₹34.85 | ₹34.85 | ₹34.85 | 0.00 (Cr) | |
| ₹34.85 | ₹34.85 | ₹34.85 | ₹34.85 | 2.00K (Cr) | |
| ₹34.50 | ₹34.50 | ₹34.50 | ₹34.50 | 0.00 (Cr) |
WALPAR NUTRITIONS — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹29.15 | ₹35.50 | ₹29.15 | ₹34.85 | +19.55% | |
| ₹31.55 | ₹31.55 | ₹21.25 | ₹27.80 | -11.89% | |
| ₹37.00 | ₹38.00 | ₹31.35 | ₹32.95 | -10.95% | |
| ₹45.50 | ₹45.50 | ₹37.00 | ₹37.00 | -18.68% | |
| ₹45.50 | ₹45.50 | ₹45.50 | ₹45.50 | +0.00% | |
| ₹45.50 | ₹45.50 | ₹45.50 | ₹45.50 | +0.00% | |
| ₹45.90 | ₹45.90 | ₹45.50 | ₹45.50 | -0.87% | |
| ₹39.60 | ₹50.60 | ₹37.70 | ₹45.90 | +15.91% | |
| ₹44.00 | ₹48.95 | ₹38.25 | ₹39.60 | -10.00% | |
| ₹39.80 | ₹46.50 | ₹39.25 | ₹44.00 | +10.55% | |
| ₹44.20 | ₹46.95 | ₹37.85 | ₹39.85 | -9.84% | |
| ₹44.95 | ₹49.05 | ₹42.05 | ₹44.20 | -1.67% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
WALPAR NUTRITIONS Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
WALPAR NUTRITIONS Fundamental Analysis & Valuation Benchmarking
Educational evaluation of WALPAR across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Attractive Valuation (P/E: 13.12 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (66.98% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (63.68% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (75.11% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (6.13x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (68.82%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Negative Free Cash Flow (₹-5.56 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
WALPAR NUTRITIONS vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare WALPAR NUTRITIONS with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
58/100 | ₹34.85₹35 | ₹32.40₹32.40 | 13.12Average 13.1 Average | 13.93%Average 13.93% Average | 14.84%Average 14.84% Average | 0.89Good 0.9 Good | 75.11%Excellent 75.11% Excellent | 66.98%Excellent 66.98% Excellent | 0.00% | |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
WALPAR NUTRITIONS PE Ratio History
Historical price-to-earnings ratio for WALPAR — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2023 | ₹0.70 | ₹82.65 | 118x |
| FY 2022 | ₹0.42 | ₹62.95 | 149.9x |
| FY 2021 | ₹0.17 | ₹29.40 | 177.8x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
WALPAR NUTRITIONS Quarterly Performance
Latest quarterly metrics for WALPAR — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
7.80%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
13.46%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
66.98%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
75.11%
Compounded annual net profit growth over 5 years
WALPAR NUTRITIONS Technical Indicators
SMA 50, SMA 200, RSI and volume signals for WALPAR — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
WALPAR NUTRITIONS Financial Statements
Annual income statement, balance sheet and cash flow for WALPAR NUTRITIONS (WALPAR) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for WALPAR NUTRITIONS
About WALPAR (WALPAR NUTRITIONS)
WALPAR NUTRITIONS (WALPAR) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a curren...t market capitalisation of ₹32.40 (Cr). WALPAR NUTRITIONS has delivered a Return on Equity (ROE) of 13.93% and a ROCE of 14.84%. The debt-to-equity ratio stands at 0.89, reflecting the company's capital structure. Investors tracking WALPAR share price can monitor key metrics including P/E ratio, promoter holding of 68.82%, and quarterly earnings growth.
Company Details
WALPAR Share Price: Frequently Asked Questions
What is the current share price of WALPAR NUTRITIONS?
WALPAR NUTRITIONS (WALPAR) trades at ₹34.85 on NSE. Market cap ₹32.40 (Cr). Educational data only.
What is the P/E ratio of WALPAR NUTRITIONS?
WALPAR NUTRITIONS has a P/E of 13.12x vs industry average 34.89x.
What is the Bull Run score for WALPAR NUTRITIONS?
WALPAR NUTRITIONS has a Bull Run score of 58/100 based on 25+ financial parameters.
Does WALPAR NUTRITIONS pay dividends?
WALPAR NUTRITIONS has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of WALPAR NUTRITIONS?
WALPAR NUTRITIONS has ROE of 13.93%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of WALPAR NUTRITIONS?
WALPAR NUTRITIONS has debt-to-equity of 0.89.
Is WALPAR NUTRITIONS a good investment?
Bull Run gives WALPAR NUTRITIONS a score of 58/100. This is not investment advice — consult a SEBI-registered advisor.